health

February 23, 2026

Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen

Eli Lilly hopes the device can be more convenient for Zepbound users and lead to more people taking the drug.

Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen

TL;DR

  • Eli Lilly introduced a new multi-dose KwikPen for its obesity drug Zepbound.
  • The pen contains a month's worth of doses, reducing the need for multiple devices.
  • Cash-paying patients can purchase the KwikPen via LillyDirect, with prices starting at $299 per month.
  • This new form aims to increase convenience and patient adherence to Zepbound treatment.
  • Zepbound has seen significant demand since its late 2023 market entry, boosting Eli Lilly's market share in weight loss drugs.
  • The KwikPen technology is already used for other Eli Lilly medications, including Mounjaro.

Continue reading the original article

Made withNostr